Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study - Hoisnard, L; Pina Vegas, L; Dray-Spira, R; Weill, A; Zureik, M; Sbidian, E (Ann Rheum Dis, 2023)